Nanobiotix S.A.
NBTXNasdaqHealthcare · Pharmaceutical Preparations · I0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Invus Global Management, LlcPassive (13G)Apr 17, 2025
- Baillie Gifford & CoPassive (13G)Feb 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 80,248 | 1.0 | +114.6% |
| Apr 30, 2026 | 37,392 | 1.0 | +232.8% |
| Apr 15, 2026 | 11,234 | 1.0 | -55.9% |
| Mar 31, 2026 | 25,474 | 1.0 | +71.8% |
| Mar 13, 2026 | 14,823 | 1.0 | -3.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KFORM 6-KMay 26, 2026
- 6-KFORM 6-KMay 26, 2026
- 6-KFORM 6-KMay 22, 2026
- FWPMay 22, 2026
- 424B5May 22, 2026
- FWPMay 21, 2026
- 6-KFORM 6-KMay 21, 2026
- 6-KFORM 6-KMay 21, 2026
- 6-KFORM 6-KMay 21, 2026
- FWPMay 21, 2026
- 6-KFORM 6-KMay 21, 2026
- 6-KMay 20, 2026
- 424B5May 20, 2026
- 6-KFORM 6-KMay 18, 2026
- 6-KFORM 6-KMay 5, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.